Volume | 25,983 |
|
|||||
News | (1) | ||||||
Day High | 1.66 | Low High |
|||||
Day Low | 1.51 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Icad Inc | ICAD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.64 | 1.51 | 1.66 | 1.64 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
175 | 25,983 | US$ 1.61 | US$ 41,738 | - | 1.14 - 3.97 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
12:46:19 | 200 | US$ 1.56 | USD |
Icad Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
40.85M | 26.35M | - | 17.32M | -4.85M | -0.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Icad News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICAD Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.61 | 1.67 | 1.45 | 1.54 | 92,977 | -0.05 | -3.11% |
1 Month | 1.43 | 1.88 | 1.40 | 1.61 | 136,630 | 0.13 | 9.09% |
3 Months | 1.75 | 1.99 | 1.40 | 1.62 | 152,284 | -0.19 | -10.86% |
6 Months | 1.75 | 2.6499 | 1.25 | 1.66 | 176,911 | -0.19 | -10.86% |
1 Year | 1.31 | 3.97 | 1.14 | 2.67 | 489,239 | 0.25 | 19.08% |
3 Years | 17.23 | 19.00 | 1.05 | 3.82 | 277,327 | -15.67 | -90.95% |
5 Years | 6.23 | 21.44 | 1.05 | 6.24 | 246,295 | -4.67 | -74.96% |
Icad Description
icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers. |